Richard Rosen, M.D.
The purpose of this research study is to determine if administration of denufosol intravitreal injection, an investigational drug not approved by the FDA, is well-tolerated and more efficacious than placebo in stimulating subretinal fluid reabsorption and retinal reattachment without surgical intervention in subjects presenting with rhegmatogenous retinal detachment (RRD).
Study results are currently being analyzed. Please visit this webpage next month for the study update.
For more information: